Myotonic Dystrophy 2

3

Review clinical trials related to Myotonic Dystrophy 2. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

An Ambispective Natural History Study in Myotonic Dystrophy Patients Linking Retrospective Data Captured From the DM-Scope Registry With a Prospective 24-month Follow-up Period

This natural history observational study is being conducted to follow patients with DM1 or DM2 over a 2 year period to study the presence of myotonia, how it's perceived and its impact on patients quality of life. This study will be conducted at 6 study sites located in France.100 Patients will be recruited from the DM Scope Registry only. The study involves two parts. Part 1 will look back up to 18 months of past medical history that is already available from the DM Scope Registry. Part 2 will follow the same patients for 24 months, with study visits at Day 1 (Baseline), 12 months and 24 months. The goal is to better understand how myotonia symptoms and complications such as heart and other systemic problems develop and change over time. A smaller, sub-study will take place at one site, using new exploratory methods in about 40 patients with DM1 who are also part of the Track DM Study.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Lupin Ltd.Updated: Jul 28, 2026Locations: 6Duration: 24 Months
Eligibility criteria

Enrolled in DM-scope registry genetically diagnosed with DM1 or DM2. [+8]

No informed consent. [+7]

Status: Recruiting

Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)

An exercise regimen (PRIME: Proximal Resistance In-House Movement Exercise) has been designed for patients with myotonic dystrophy type 2 (DM2). The hypothesis is that this patient-friendly physical therapist (PT)-guided exercise program associates with improved functional capacity and muscle composition in DM2 in this two-period two-sequence cross-over study. Thus, participant will be randomized to one of the three possible groups. Participants in GROUP A will perform exercise routine virtually under the direct supervision of a physical therapist once a week and another session on their own for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP B will perform exercise routine virtually under the direct supervision of a physical therapist twice a week for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP C will perform exercise routine on their own during the first 3 months, then they will perform exercise routine virtually under the direct supervision of a physical therapist. Each group will include around 8 participants. Duration of the study is 6 months. In addition to exercise sessions, participants will have evaluation of their strength, motor function and muscle composition at three time points: initiation, 3 months and completion of the study at 6 months. Muscle composition will be assessed by electrical impedance myography which is a portable, non-invasive, painless and non-radiation tool that applies a weak high multifrequency electrical current to the examined muscle and allows to obtain information about its composition.

Participants needed: 24
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Massachusetts General HospitalUpdated: Apr 15, 2026Locations: 1
Eligibility criteria

Patients with genetically confirmed myotonic dystrophy 2 (DM2) who are ≥18 and ≤... [+3]

Subjects younger than 18 years old or older than 70 years old. [+7]

Status: Recruiting

Myotonic Dystrophy Family Registry

The Myotonic Dystrophy Family Registry (MDFR) is an online, patient-entered database that collects information on myotonic dystrophy (DM) to aid researchers in developing new, effective treatments and help identify participants for research studies and clinical trials.

Participants needed: 3,500
Trial details
Biological sex: AllType: ObservationalSponsor: Myotonic Dystrophy FoundationUpdated: Nov 21, 2024Locations: 1Duration: 5 Years
Eligibility criteria

Diagnosed with congenital, juvenile-onset or adult onset DM1 or DM2 (confirmed b...

Not diagnosed with DM, unaffected family members